跳至主要内容
临床试验/NCT02669368
NCT02669368Unknown2 期

Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy

Assiut University1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2015年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
75
试验地点
1
主要终点
The time of onset the action of Rocuronium

研究概览

简要总结

This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose rocuronium, intubation condition and surgical condition in patients undergoing laparoscopic cholecystectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists physical status 1 or
  • BMI of 25-34.9 kg/m
  • Patients scheduled for laparoscopic cholecystectomy.

排除标准

  • Severe respiratory or cardiac disease.
  • Hepatic or renal function impairment.
  • Neuromuscular disease.
  • Patients on medications affecting neuromuscular function.
  • Patients with known allergy to the drugs.

研究组 & 干预措施

Standard dose Rocuronium

Active Comparator

Pretreatment of saline 100ml then giving Rocuronium 0.6 mg/kg at induction of anesthesia.

干预措施: Saline (Drug)

Standard dose Rocuronium

Active Comparator

Pretreatment of saline 100ml then giving Rocuronium 0.6 mg/kg at induction of anesthesia.

干预措施: Standard dose Rocuronium (Drug)

Low dose Rocuronium

Active Comparator

Pretreatment of saline 100ml then giving Rocuronium 0.45 mg/kg at induction of anesthesia.

干预措施: Saline (Drug)

Low dose Rocuronium

Active Comparator

Pretreatment of saline 100ml then giving Rocuronium 0.45 mg/kg at induction of anesthesia.

干预措施: Low dose Rocuronium (Drug)

Low dose Rocuronium + Magnesium Sulfate

Active Comparator

Pretreatment of Magnesium sulfate 30 mg/kg then giving Rocuronium 0.45 mg/kg at induction of anesthesia.

干预措施: Magnesium Sulfate (Drug)

Low dose Rocuronium + Magnesium Sulfate

Active Comparator

Pretreatment of Magnesium sulfate 30 mg/kg then giving Rocuronium 0.45 mg/kg at induction of anesthesia.

干预措施: Low dose Rocuronium (Drug)

结局指标

主要结局

The time of onset the action of Rocuronium

时间窗: Time from injection of Rocuronium till T1 suppression more than 95% up to 10 minutes.

by using the TOF watch nerve stimulator

The time at which Maximal suppression

时间窗: Time from the injection of Rocuronium to T1 maximal suppression time (TOF=0) up to an hour.

by using the TOF watch nerve stimulator

Reversal of Rocuronium

时间窗: Time from injection of Rocuronium till reversal of T1 (TOF=25%) around an hour after induction of anesthesia

by using the TOF watch nerve stimulator

次要结局

  • Surgical condition(During surgery)
  • Intubation condition(Within 10 minutes after induction of anesthesia)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Hamada Hamed

Dr.

Assiut University

研究点 (1)

Loading locations...

相似试验